Marcell Baranyi

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines.

Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines.

Journal: Biological trace element research

Published: February 26, 2026

Renaissance of farnesyltransferase inhibitors in cancer.

Renaissance of farnesyltransferase inhibitors in cancer.

Journal: Journal of translational medicine

Published: February 23, 2026

Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma.

Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma.

Journal: Scientific reports

Published: April 07, 2025

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer.

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer.

Journal: Pathology oncology research : POR

Published: August 29, 2024

Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer.

Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 11, 2024

Mapping protein binding sites by photoreactive fragment pharmacophores.

Mapping protein binding sites by photoreactive fragment pharmacophores.

Journal: Communications chemistry

Published: June 01, 2024

Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma.

Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma.

Journal: Scientific reports

Published: February 20, 2024

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development.

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development.

Journal: International journal of molecular sciences

Published: December 19, 2023

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.

Journal: British journal of cancer

Published: June 01, 2023

Farnesyltransferase inhibitors have antitumoral effects in mutant KRAS containing cancer cells in preclinical models

Farnesyltransferase inhibitors have antitumoral effects in mutant KRAS containing cancer cells in preclinical models

Journal: Magyar onkologia

Published: April 30, 2023

Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma.

Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 28, 2023

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.

Journal: International journal of molecular sciences

Published: February 23, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026